ProNGF AS A NEW BIOMARKER IN THYROID CANCER
IDENTIFICATION AND SYNERGISTIC TARGETING OF FLT3-ACTIVATED PATHWAYS IN ACUTE MYELOID LEUKAEMIA
EPHA2 ANTIBODY INCREASES SENSITIVITY OF U87 GLIOBLASTOMA CELLS TO IRRADIATION
AIMING FOR THE RIGHT QUALITY IMPROVEMENT TARGET: CROSS-SECTIONAL DATA EXPLORING OUTPATIENTS' PRIORITIES AND PREFERENCES FOR QUALITY IMPROVEMENT IN TERTIARY CLINICS
THE TOBACCO SMOKING PROFILE OF CLIENTS ATTENDING A MEDICALLY SUPERVISED INJECTING CENTRE
DEVELOPMENT OF ACTION LIMITS FOR PATIENT ERROR DETECTION FOR AN EPID-BASED REAL-TIME DELIVERY VERIFICATION SYSTEM
ASSESSMENT OF BLOOD TRANSFUSION PRACTICES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN THE ERA OF HYPOMETHYLATING AGENTS.
PREDICTORS OF MDT REVIEW AND THE IMPACT ON LUNG CANCER SURVIVAL FOR HNELHD RESIDENTS TREATED IN THE PUBLIC SECTOR
MONTE-CARLO SIMULATIONS OF THE CLINICAL BENEFITS FROM THERAPEUTIC DRUG MONITORING OF SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOURS
PANEL TESTING FOR BREAST CANCER RISK ASSESSMENT: IS IT JUST BECAUSE WE CAN RATHER THAN SHOULD?
PATIENT PERSPECTIVES ON ISSUES OF ACCESS TO CANCER CARE ACROSS THE CARE CONTINUUM
DEVELOPMENT OF NOVEL MULTIPLE REACTION MONITORING (MRM) ASSAY FOR BIOMARKER QUANTITATION IN CANCER CELLS
ASSESSMENT OF EPIDEMIOLOGIC PROFILE OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN HUNTER REGION
THE EFFECTS OF ALTERED CD9 AND CD151 EXPRESSION ON PROSTATE EXOSOMES
IS VTE PROPHYLAXIS SAFE IN HAEMATOLOGICAL CANCERS UNDERGOING AUTOLOGOUS TRANSPLANTATION?
TECHNIQUES FOR IMPROVING EMOTIONAL CONTENT OF ONLINE COMMUNICATIONS – A SYSTEMATIC REVIEW
ADVANCING COLLABORATIVE QUALITY IMPROVEMENT IN TERTIARY SETTINGS: DO CHRONIC DISEASE OUTPATIENTS AND HEALTH PROFESSIONALS IDENTIFY SIMILAR TYPES AND NUMBERS OF QUALITY INITIATIVES?
THERAPEUTIC DRUG MONITORING FOR CANCER PATIENTS RECEIVING CHEMOTHERAPY
EVIDENCE-PRACTICE GAPS FOR AUSTRALIAN GENERAL PRACTITIONERS (GP) IN ASSISTING PREGNANT WOMEN TO QUIT
INDIGENOUS COUNSELLING AND NICOTINE (ICAN) QUIT IN PREGNANCY – DEVELOPING AN EVIDENCE-BASED INTERVENTION FOR SMOKING CESSATION FOR INDIGENOUS PREGNANT WOMEN
DEVELOPING A NOVEL MOUSE MODEL OF LUNG CANCER
PROSTATE CANCER BIOMARKERS: ARE EXTRACELLULAR VESICLES THE SOLUTION?
A NEW VENTURE FOR THE HUNTER CANCER BIOBANK-ESTABLISHMENT OF SEQUENTIAL BLOOD COLLECTION FOR BRAIN CANCER RESEARCH
SIFTING DATA FROM THE CLINICAL COALFACE: DATAMINING IN RADIATION ONCOLOGY TO AID CLINICAL DECISIONS
DETERMINING THE MECHANISM OF LEUKAEMOGENESIS INDUCED BY SHWACHMAN-DIAMOND SYNDROME (SDS) USING COMPARATIVE AND QUANTITATIVE PROTEOMICS
CHEMICAL PROTEOMICS TO IDENTIFY THE MECHANISM OF PROTEIN PHOSPHATASE 2A (PP2A) INHIBITION IN ACUTE MYELOID LEUKAEMIA (AML)
A SURVEY OF MEDICAL STUDENTS' UNDERSTANDING AND ATTITUDE TOWARDS MEDICAL ONCOLOGY: A PILOT STUDY
ROLE OF REDUCED PROTEIN PHOSPHATASE 2A SUBUNIT, B55A, EXPRESSION IN LUMINAL B BREAST CANCER CELL LINE DNA DAMAGE REPAIR PATHWAY
A CLINICAL PRACTICE CHANGE INTERVENTION TO INCREASE DIETITIAN PROVISION OF DEPRESSION SCREENING AND REFERRAL FOR HEAD AND NECK CANCER PATIENTS
CONTINUED TOBACCO SMOKING, ALCOHOL USE AND DEPRESSIVE SYMPTOMS IN A SAMPLE OF HEAD AND NECK CANCER PATIENTS ABOUT TO UNDERGO RADIOTHERAPY
BASAL-LIKE BREAST CANCER SUBGROUPS UNCOVERED BY GENOMIC AND TRANSCRIPTOMIC PROFILES AND OVERALL SURVIVAL OUTCOMES
EPID DOSIMETRY FOR CREDENTIALING IMRT TREATMENTS OF DIFFERENT CENTRES
ASSOCIATION OF THE POLYMORPHIC INTRON 3 16 BP DUPLICATION IN TP53 (RS17878362) WITH A LOW Δ40P53:P53 RATIO AND BETTER OUTCOME IN BREAST CANCER
THE ESSENTIAL ROLE OF ANATOMICAL PATHOLOGISTS IN TISSUE BIOBANKING – A WIN- WIN SITUATION
REDUCED EXPRESSION OF PROTEIN PHOSPHATASE 2A SUBUNIT, B55A, IN BREAST CANCER DNA DAMAGE REPAIR PATHWAYS
BAALC CAN CONTROL THE SENSITIVITY OF AML CELLS TO CHEMOTHERAPEUTICS
A NOVEL COMBINATORIAL OPTIMISATION APPROACH FOR FEATURE SELECTION VIA INTEGRATION OF INFORMATION FROM MULTIPLE DATASETS
CHARACTERISATION OF A NOVEL PP2A INHIBITORY ONCOPROTEIN IN ACUTE MYELOID LEUKAEMIA (AML)
THE PROTEIN PHOSPHATASE INHIBITOR CANTHARIDIN, POTENTIATES THE EFFECT OF ALL-TRANS RETINOIC ACID IN ACUTE PROMYLOCYTIC LEUKEMIA CELLS
ENHANCING THE EFFICACY OF TYROSINE KINASE INHIBITORS THROUGH BIO-POLYMERIC ALBUMIN HYBRID NANOPARTICLES IN BREAST CANCER
PATHWAYS TO SMOKING CARE IMPLEMENTATION PROJECT: STAGE 2
COMPARING DIGITAL VERSUS VISUAL SCORING METHODS FOR IMMUNOHISTOCHEMICAL STAINING: A CASE STUDY IN THE HUNTER CANCER BIOBANK
HOW INTRINSIC ARE LUMINAL BREAST CANCER SUBTYPES?
REVISION OF MOLECULAR BREAST CANCER SUBTYPES
THE EFFECTIVENESS OF THE PUBLIC DIRECT ACCESS COLONOSCOPY SERVICE IMPLEMENTED AT JOHN HUNTER HOSPITAL
IDENTIFYING THE FUNCTIONAL ROLE OF TSR, A NOVEL DRUG TARGET IN AML
DEVELOPMENT AND TESTING OF A DECISION AID FOR WOMEN CONSIDERING NEOADJUVANT SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER (STUDY IN PROGRESS)
THE SEARCH FOR NOVEL TREATMENT AGENTS FOR PANCREATIC CANCER: TALES FROM THE LAND AND SEA
A BISPIDINONE ANALOGUE INDUCES AN APOPTOSIS-MEDIATED CYTOTOXIC EFFECT ON PANCREATIC CANCER CELLS IN VITRO